News

(Bloomberg) -- Investors are scrambling to decide if Donald Trump’s impending return to the White House will sustain or derail the rally in emerging-market bonds witnessed under Joe Biden.Most Read from BloombergRiyadh Metro Partially Opens in Bid to Ease City’s Traffic JamsAs Wars Rage, Cities Face a Dark New Era of Urban DestructionAccording to Jeff Grills, head of US cross-asset and emerging-markets debt at Aegon Asset Management, whether equities or bonds benefit most from Trump’s second pre

Mike Wesley, who spent 14 years in marketing positions at the fried chicken brand, will help the casual chain amplify brand awareness and drive marketing and promotional activities.

(Bloomberg) -- Buyout firm Advent is contemplating setting up an investment vehicle targeting mid-sized transactions as it looks to bolster its core private equity business.Most Read from BloombergRiyadh Metro Partially Opens in Bid to Ease City’s Traffic JamsAs Wars Rage, Cities Face a Dark New Era of Urban DestructionAdvent, which is focused on buying controlling stakes in businesses, raised $25 billion for its flagship buyout fund in 2022 — its largest fundraising to date. The firm sees a “fi

On Monday, Purple Biotech Ltd (NASDAQ:PPBT) reported the final results from the randomized Phase 2 study of its lead oncology drug, CM24, a humanized monoclonal antibody that blocks CEACAM1, in patients with pancreatic ductal adenocarcinoma (PDAC). Purple Biotech stock is trading higher with a strong session volume of 9.7 million, compared to an average volume of 48.73K as per data from Benzinga Pro. The Phase 2 study evaluated CM24 in combination with Bristol Myers Squibb & Co’s (NYSE:BMY) immu

Stocks generally enjoyed one of the best months of the year. Here's what else you should know about the markets into year-end.

News that chip giant Intel will get a new CEO set the embattled chip maker's shares in motion Monday, with the stock finishing marginally lower as the company sought to reassure investors that things might improve after a punishing year.

Projected earnings growth, if delivered, could render a bullish Wall Street actually being too cautious.